Singapore infuses another $1B into R&D fund

R&D in Singapore will get a government-funding boost. The country's National Research Fund will get an extra $1 billion in its budget for the coming year. That's on top of a $1.5 billion addition to the $5 billion fund last year. The fund has backed cancer research, as well as R&D in other industries.

What's more, the government is aiming to increase the private sector's share of R&D funding. Finance Minister Tharman Shanmugaratnam said during a speech that Singapore would be allocating more funding to "[support] private-sector R&D activity and commercialization," the Straits Times reports.

The government is investing in R&D in hopes of developing a "broader base of innovative enterprises" in the Singapore economy, Shanmugaratnam said. It's hoping it can leverage public R&D funding into bigger research investments from the private sector, with a long-term goal of boosting research to 3.5 percent of GDP from its current 3 percent.

- read the Straits Times story

Suggested Articles

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.

Efforts to pivot existing discoveries into COVID-19 cures may not bear fruit until the pandemic has ended but could help fend off future outbreaks.